Dario Amodei acknowledges that AI companies have fallen short of their commitments.

      Dario Amodei posted on X that the most valid criticism of AI companies, including Anthropic, is their failure to fulfill their promises, emphasizing that only true breakthroughs will earn public trust. This statement comes as Anthropic approaches a listing, which investors anticipate will value the company at $2 trillion.

      Amodei acknowledged the critique aimed at his industry. “The most valid criticism of AI companies, including Anthropic, is that we haven't yet realized our lofty promises to benefit the world,” he mentioned on X on Saturday. His suggestion is more direct than his acknowledgment. “At this point, claiming that AI will cure cancer feels more like a cliché than an inspiration, and most people perceive it as misleading,” he noted. “What will truly matter is actually curing cancer.”

      The timing of his remarks adds significance. Anthropic is weeks away from a listing expected to value the firm at $2 trillion in October, a valuation heavily reliant on future technological potential rather than past accomplishments.

      Public opinion backs his assertion. Pew Research found that half of American adults are more worried than excited about AI in everyday life, compared to just 10% who feel excited, a rise from 37% concerned since the question was first posed in 2021.

      However, he does not attribute this concern to his own warnings. “I do not concur that my messaging has been overly negative,” he stated, referencing his 2024 essay, "Machines of Loving Grace," which argues that AI could bring positive transformations to the world.

      His reasoning is more extensive and difficult to validate. He contended that the public's distrust of AI companies is a reflection of decades of skepticism toward corporations in general, asserting, “AI is just the latest manifestation of this.”

      Others remain skeptical that breakthroughs alone are sufficient. An OpenAI employee responded that the pharmaceutical industry continually provides advancements yet remains one of the least trusted sectors. She argued that public perception of AI companies will be influenced by more than just achievements, including aspects like pricing, accessibility, lobbying efforts, transparency, how benefits are distributed, and who holds power.

      Yann LeCun presented an argument that Anthropic may find uncomfortable. He asserted that the only viable path forward involves AI that is “widely available, shared, and open,” a stance Anthropic opposes regarding its advanced models, while Meta advocates for a different approach in Washington.

      Amodei concluded with a timeline. Anthropic anticipates “remarkable results in the upcoming years, with some initial glimpses in the next few months,” placing the listing comfortably ahead of any anticipated developments.